ArticleClinical and translational science2021

Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing.

Akinyemi Oni-Orisan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.